Advertisement
Canada markets close in 1 hour 37 minutes

  • S&P/TSX

    21,970.98
    +85.60 (+0.39%)
     

  • S&P 500

    5,105.87
    +57.45 (+1.14%)
     

  • DOW

    38,284.45
    +198.65 (+0.52%)
     

  • CAD/USD

    0.7318
    -0.0005 (-0.07%)
     

  • CRUDE OIL

    83.90
    +0.33 (+0.39%)
     

  • Bitcoin CAD

    87,377.04
    -1,110.18 (-1.25%)
     

  • CMC Crypto 200

    1,333.11
    -63.43 (-4.54%)
     

  • GOLD FUTURES

    2,351.90
    +9.40 (+0.40%)
     

  • RUSSELL 2000

    2,004.03
    +22.91 (+1.16%)
     

  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     

  • NASDAQ

    15,933.14
    +321.38 (+2.06%)
     

  • VOLATILITY

    15.08
    -0.29 (-1.89%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Latest stubborn U.S. inflation reading will bring about more 'wait and see' from the Fed

2 Coronavirus Stocks to Avoid This Month

Alex Carchidi, The Motley Fool
·4 min read
2 Coronavirus Stocks to Avoid This Month

Inovio Pharmaceuticals (NASDAQ: INO) and Gilead Sciences (NASDAQ: GILD) are major competitors in the growing market for coronavirus products, making both tantalizing stock picks. Inovio's stock has soared this year thanks to its INO-4800 coronavirus vaccine project, which has so far proven effective at producing immunity in primates. In contrast, Gilead's stock has consistently struggled despite the commercialization of its antiviral drug, remdesivir, which may be effective at helping patients recover from COVID-19.

Continue reading